152 related articles for article (PubMed ID: 11567753)
1. Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization.
Nagata T; Higashi T; Aoshi T; Suzuki M; Uchijima M; Koide Y
Vaccine; 2001 Oct; 20(1-2):105-14. PubMed ID: 11567753
[TBL] [Abstract][Full Text] [Related]
2. Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain.
Nagata T; Aoshi T; Suzuki M; Uchijima M; Kim YH; Yang Z; Koide Y
Infect Immun; 2002 May; 70(5):2676-80. PubMed ID: 11953411
[TBL] [Abstract][Full Text] [Related]
3. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
6. Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.
Lu X; Wu S; Blackwell CE; Humphreys RE; von Hofe E; Xu M
Immunology; 2007 Feb; 120(2):207-16. PubMed ID: 17116173
[TBL] [Abstract][Full Text] [Related]
7. Induction of antigen specific CD4+ T cell responses by invariant chain based DNA vaccines.
van Tienhoven EA; ten Brink CT; van Bergen J; Koning F; van Eden W; Broeren CP
Vaccine; 2001 Jan; 19(11-12):1515-9. PubMed ID: 11163676
[TBL] [Abstract][Full Text] [Related]
8. Enhanced CD4+ T-cell response in DR4-transgenic mice to a hybrid peptide linking the Ii-Key segment of the invariant chain to the melanoma gp100(48-58) MHC class II epitope.
Kallinteris NL; Wu S; Lu X; Humphreys RE; von Hofe E; Xu M
J Immunother; 2005; 28(4):352-8. PubMed ID: 16000953
[TBL] [Abstract][Full Text] [Related]
9. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
10. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
11. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
12. The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses.
Chaturvedi P; Hengeveld R; Zechel MA; Lee-Chan E; Singh B
Int Immunol; 2000 Jun; 12(6):757-65. PubMed ID: 10837403
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
14. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
[TBL] [Abstract][Full Text] [Related]
15. Induction of T cell responses to the invariant chain derived peptide CLIP in mice immunized with the group 1 allergen of house dust mite.
Kristensen NM; Hoyne GF; Hayball JD; Hetzel C; Bourne T; Lamb JR
Int Immunol; 1996 Jul; 8(7):1091-8. PubMed ID: 8757954
[TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization.
Inchauspe G; Vitvitski L; Major ME; Jung G; Spengler U; Maisonnas M; Trepo C
DNA Cell Biol; 1997 Feb; 16(2):185-95. PubMed ID: 9052739
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility class II peptide occupancy, antigen presentation, and CD4+ T cell function in mice lacking the p41 isoform of invariant chain.
Takaesu NT; Lower JA; Robertson EJ; Bikoff EK
Immunity; 1995 Sep; 3(3):385-96. PubMed ID: 7553002
[TBL] [Abstract][Full Text] [Related]
18. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms.
Shachar I; Elliott EA; Chasnoff B; Grewal IS; Flavell RA
Immunity; 1995 Sep; 3(3):373-83. PubMed ID: 7553001
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
Toda M; Kasai M; Hosokawa H; Nakano N; Taniguchi Y; Inouye S; Kaminogawa S; Takemori T; Sakaguchi M
Eur J Immunol; 2002 Jun; 32(6):1631-9. PubMed ID: 12115646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]